Ingevity Corp Files 8-K on Director/Officer Changes
Ticker: NGVT · Form: 8-K · Filed: Mar 10, 2025 · CIK: 1653477
| Field | Detail |
|---|---|
| Company | Ingevity Corp (NGVT) |
| Form Type | 8-K |
| Filed Date | Mar 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-compensation, board-of-directors
Related Tickers: NGVT
TL;DR
Ingevity's board is shuffling, expect news on exec pay soon.
AI Summary
On March 10, 2025, Ingevity Corporation filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing indicates a departure of a director and potentially new appointments or changes to officer compensation, though specific names and dollar amounts for these changes are not detailed in this initial summary.
Why It Matters
Changes in a company's board of directors and executive compensation can signal shifts in strategy, governance, or financial outlook, impacting investor confidence.
Risk Assessment
Risk Level: low — This filing is procedural, reporting standard corporate governance changes without immediate financial implications.
Key Players & Entities
- Ingevity Corporation (company) — Registrant
- March 10, 2025 (date) — Date of Report
FAQ
What specific changes were made to Ingevity Corporation's board of directors?
The filing indicates a departure of a director, but specific names are not provided in the initial summary.
Are there any new executive officers appointed?
The filing mentions 'Appointment of Certain Officers' as an item, suggesting potential new appointments or changes, but details are not specified.
What is the nature of the compensatory arrangements being reported?
The filing lists 'Compensatory Arrangements of Certain Officers' as an item, indicating updates or new information regarding executive pay, but specific details are not yet available.
When was this 8-K report filed?
The report was filed on March 10, 2025.
What is Ingevity Corporation's principal executive office address?
The principal executive offices are located at 4920 O'Hear Avenue, Suite 400, North Charleston, South Carolina 29405.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 10, 2025 regarding Ingevity Corp (NGVT).